On the point of view of President Donald Trump’s Monday announcement of an executive order that will reduce the prices of recipe medicines in the United States, the point of view of current costs and the amount of North -Americans could save.
The President’s order calls for “more favored drug prices”, which means “the lowest price paid by a drug in other developed countries, this is the price that the North -Americans will pay,” he said.
“Some recipe and pharmaceutical medicine prices will reduce almost 50 to 80 and 90%immediately,” said Trump.
President Trump assumes “Big Pharma” by signing the executive order to reduce drug prices
Katy Dubinsky, a pharmacist and founder of New York and a counselor to Vitalize, applauded the measure to reduce prescription prices, noting that Trump’s order treats a long -term problem.
“But this will not be easy to perform,” he told Fox News Digital.
Following the announcement of President Trump of an executive order that will reduce the prices of prescription medicines in the United States, the point of view is about current costs and the amount of North -Americans. (Istock)
“The executive order does not reduce the costs immediately,” he said. “He addresses government agencies to begin drafting the rules, which can take months.”
Here are the five most expensive recipe medicines in the United States by price, followed by five per volume.
5 most expensive recipe drugs in the United States
Dubinsky detailed some of the most expensive recipe medicines in the country and what conditions they treat.
1.
This drug is used to treat methacrromatic leukodistrophy (MLD), a rare genetic disorder that damages the nervous system, said Dubinsky.
“It occurs once and is supposed to stop or slow down the disease in young children,” he said.
The 10 U.S. allergy “capitals”, as well as 4 tips for managing symptoms
2. Hemgenix (Etranacogene Dezaparvovec-Drlb) by CSL Behring-3.5 million
This drug is prescribed for people with hemophilia B, a bloody disorder.
“This unique treatment helps the body to make its own coagulation factor, so that patients do not need regular infusions,” said Dubinsky.
3.
This recipe medication, aimed at young boys, deals with Duchenne’s muscular dystrophy (DMD), a condition that weakens the muscles over time.
“It aims to stop the speed of the disease,” said Dubinsky.
The president’s order calls for “more favored prices for nations drug”, which means “the lowest price paid by a drug in other developed countries, this is the price that the North -Americans will pay.” (Istock)
4. Skysona (ElivaldOgene Autotemcel) from Bluebird Bio – $ 3 million
“This drug is used for the adrenoleukodistrophy (CALD), a serious brain disease in the boys,” said Dubinsky. “This therapy tries to delay damage before the symptoms get worse.”
5. Zynteglo (Betiboglene Autotemcel) of Bluebird Bio – 2.8 million dollars
Zynteglo is for Beta-Talassemia, a blood state that usually requires regular transfusions.
“Some recipe and pharmaceutical medicine prices will reduce almost 50 to 80 and 90%almost immediately.”
“This gene therapy can help patients make healthy red blood cells and reduce how often they need treatment,” said Dubinsky.
5 best more expensive drugs per sales volume
John Stanford, Executive Director of Incubate, a Washington Coalition of Investors in Initial Life Sciences, shared his thoughts on the five best more expensive medicines per sales volume.
“Normally, when the government focuses on the most expensive drugs, they focus on the volume of sales volume in place, for example, a rare disease therapy with a high list of list, but a smaller patient pool,” Digital News News told.
“Often, officials focus on the total medication expenditure by Medicare or other government programs.”
“Usually, when the government focuses on the most expensive drugs, they focus on the volume of sales volume in place, for example, a rare disease therapy with a high list of list, but a smaller patient pool.” (Istock)
1. Keytruda (Pembrolizumab) of Merck – Income of $ 25 billion (2023)
Keytruda is a medicine of immunotherapy used to treat a variety of cancers, such as melanoma, non -small cell lung cancer, liver cancer and others.
“Keytruda has become the Merck Crown Jewel, helping the company to expand its cancer treatment portfolio with more than 1,000 active clinical trials,” Stanford told Fox News Digital.
Patient of terminal colon cancer saved by innovative treatment
2. ELIQUIS (Apixaban) by Bristol Myers Squibb and Pfizer – $ 18.95 million
ELIQUIS (Apixaban) is a “anchoring drug” for both BMS and Pfizer, according to Stanford.
Apixaban is prescribed to prevent the formation of blood clots and to treat the thrombosis of deep veins and the pulmonary embolism (a blood clot in the lungs).
3. Ozempic (Semaglutide) by Novo Nordisk – $ 13.93 million
Prescribed for type 2 diabetes, the Ozempic Semaglutine drug has become widely popular for its weight loss effects and other health benefits.
Prescribed for type 2 diabetes, the Ozempic Semaglutine drug has become widely popular for its weight loss effects and other health benefits. (Reuters/Hollie Adams/Photo photo)
“Ozempic sales feed Novo Nordisk’s broadest to GLP-1s for obesity, heart disease and liver conditions, all areas with high development costs and uncertain scientific results,” Stanford told Fox News Digital.
“Money has gone to expand production to meet GLP-1 demand and prevent shortage of supply.”
4. Humira (ABBVIE) – $ 14.4 billion (US 2023 income)
“Humira has been one of the most important medicines in history, generating more than $ 200 billion during its exclusivity period,” said Stanford.
The injectable drug, which contains the Adalimumab of active ingredient, is used to treat rheumatoid arthritis and other inflammatory conditions.
Click here to register -you are in our health newsletter
5. Gilead Biktarvy – 11.85 billion dollars
Biktarvy is a HIV treatment that includes the three bictegravir ingredients, emetricitabin and Alafenamide Tenophovir.
“Biktarvy is not only a main treatment of HIV, it is Gilead’s spine in cancer research,” said Stanford.
Which medicines could be affected?
Dr. Jacob Glanville, CEO of Centivax, a San Francisco Biotechnology Biotechnology company, said that vaccines and most generic drugs will not be changed by executive order.
“Most vaccines that North -Americans have a cost of less than one hundred dollars, while generic drugs are usually less than a dollar,” he told Fox News Digital.
“From the perspective of a patient, the price of medical care in the United States is unsustainable and extremely expensive medicine is part,” said an expert. “However, the insurance system and the hospital business also contribute.” (Istock)
What would be affected, predicted Granville, are more recent brands still under IP exclusivity, antibody therapies, cell therapies, gene therapies and custom cancer vaccines.
“Some of these are expensive, from $ 100,000 to $ 500,000 for a treatment course for a patient. However, they are also often the most effective treatments for certain cancers, autoimmune disorders or rare diseases.”
The price of innovation?
The pharmaceutical industry could argue that reducing these drug prices will lead to a “dramatic investment reduction” in creating these advances, said Glanville.
The industry can also argue that these medicines become generic, at which time prices are down, according to the expert.
For more health items, visit www.foxnews.com/health
“From a patient’s perspective, the price of medical care in the United States is unsustainable and extremely expensive medicine is part of it,” he said. But “the hospital insurance system and the business are also contributing.”
“If the prices of new drugs are limited, an effort should be made to reduce the cost of clinical trials and the manufacture of GMP of medicines. Otherwise, we will lose a lot of innovation.”
Click here to get the Fox News app
Greg Norman of Fox News Digital contributed to reports.
#expensive #expensive #recipe #medications #price #volume #sales
Image Source : www.foxnews.com